Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Detailed Action
Applicant’s election of Group I, claims 1-15 following claim amendments in the reply filed on 09/10/2026 is acknowledged. Examiner would like to point out that applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, and because applicants’ did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.03(a)).The restriction requirement is still deemed proper and is therefore made FINAL. Amended Claims 1-15 are pending in this application and is now under consideration for examination.
RE: Priority
Applicants’ claim for the benefit of a prior-filed applications under 35 U.S.C. 120, 121, or 365(c) or under 35 U.S.C. 119(e) is acknowledged. This application is a CON of 18/641,275 filed on 04/19/2024, now ABN, which is a CON of 17/570,312 filed on 01/06/2022 now US PAT 12,195,392, which is a CON of 16/781,622 filed on 02/04/2020, now, ABN, which is a CON of 15/066,692 filed on 03/10/2016, now, ABN, which claims benefit of Provisional Applications: 62/200,288 filed on 08/03/2015; 62/188,556 filed on 07/03/2015; and 62/130,854 filed on 03/10/2015. However, please note that the instant claims are only granted the priority date of 15/066,692 filed on 03/10/2016; specifically the subject-matter of claims 1 and11 i.e., “the calcium carbonate bonds are formed from biological activity of the urease-producing cells at a pressure that is greater than ambient pressure”.
Claim Rejections: 35 USC § 103
The following is a quotation of 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action:
(a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102 of this title, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negatived by the manner in which the invention was made.
This application currently names joint inventors. In considering patentability of the claims under 35 U.S.C. 103(a), the examiner presumes that the subject matter of the various claims was commonly owned at the time any inventions covered therein were made absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and invention dates of each claim that was not commonly owned at the time a later invention was made in order for the examiner to consider the applicability of 35 U.S.C. 103(c) and potential 35 U.S.C. 102(e), (f) or (g) prior art under 35 U.S.C. 103(a).
The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103(a) are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
Claims 1-15 are rejected under 35 U.S.C. 103(a) as being unpatentable over Dosier GK., (US 8,951,786 B1) and further in view of Kucharski et al., (US 8,182,604 B2), Paul VG., (PhD., Thesis., Missouri Univ. Sci. Technol., 2014, pages 1-257), Wilson et al., (US 10,125,303 B2) and Nemati et al., (Enz. Microbial Technol., 2003, Vol. 33: 635-642).
Regarding claims 1-7 and 12-15, Dosier GK., (US 8,951,786 B1) disclose a method for producing construction material utilizing loose pieces of aggregate, enzyme producing bacteria, an amount of urea and an amount of calcium ions. A first solution is prepared which includes urease which is formed by enzyme producing bacteria. A second solution is prepared which includes urea and calcium ions. The first and second solutions are added to the loose aggregate. The calcium ions contribute to the formation of calcium carbonate wherein the calcium carbonate fills and bonds between at least some of the gaps between the loose pieces of aggregate forming a solid construction material (Abstract and entire document).
Regarding claims 2-5, Dosier GK., in Fig. 1-2, disclose incubating the aggregate mixture includes incubating the aggregate mixture while the aggregate mixture is within a formwork that includes one or more porous panels and wherein: the one or more porous panels include a perforated panel or a bottom panel, porous mold and compacting device.
Regarding claims 1, 6-8 and 12-15, Dosier GK., in Fig. 3 and 5 and in the following sections disclose various aggregates, enzyme producing cells and said composition further comprising polymers; see col. 3, lines 29-48; col. 4, lines 35-67; Col. 5, lines 55-67 to Col. 6, lines 1-10 (reproduced below):
US 8,728,365 B2
Col. 3, lines 29-48
PNG
media_image1.png
234
272
media_image1.png
Greyscale
Col. 4, various aggregates; and Claim 14
PNG
media_image2.png
392
274
media_image2.png
Greyscale
Col. 5, lines 55-67 to Col. 6, lines 1-10
PNG
media_image3.png
146
274
media_image3.png
Greyscale
PNG
media_image4.png
116
278
media_image4.png
Greyscale
PNG
media_image5.png
674
374
media_image5.png
Greyscale
PNG
media_image6.png
594
366
media_image6.png
Greyscale
Dosier GK., is silent regarding in said method the calcium carbonate bonds are formed from biological activity of the urease-producing cells at a pressure that is greater than ambient pressure… wherein: the calcium carbonate bonds are formed at a pressure that is greater than ambient pressure and less than 100 psi (as in claims 1 and 11); further comprising: adding a suspension or pump-able slurry of the urea-producing cells and wherein: the second composition comprises a pumpable slurry (as in claims 8-9) and wherein: a urease concentration during incubation of the aggregate mixture is between 0.1 and 100 mg/ml (as in claim 10).
Regarding claims 1 and 11, the following references provide teaching suggestion and motivation for optimal pressure for the calcium carbonate bonds are formed from biological activity of the urease-producing cells at a pressure that is greater than ambient pressure… wherein: the calcium carbonate bonds are formed at a pressure that is greater than ambient pressure and less than 100 psi:
Kucharski et al., (US 8,182,604 B2), discloses microbial biocementation methods and compositions comprising separately (i) urease producing micro-organism; (ii) urea; and (iii) calcium ions and are combined to form the biocement (Abstract; Summary of Invention, Col. 1, lines 42-67; col. 5, lines 15-61; and entire document); Kucharski et al., in said method specifically teach calcium carbonate bonds are formed from biological activity of the urease-producing cells at a pressure of 7.5 psi (see Example 3, reproduced below). Applicants’ are directed to the following sections Kucharski et al., (US 8,182,604 B2):
US 8,182,604 B2
PNG
media_image7.png
267
327
media_image7.png
Greyscale
Regarding claims 1 and 11, Paul VG., (PhD., Thesis., Missouri Univ. Sci. Technol., 2014, pages 1-257), provide teaching suggestion and motivation regarding optimal pressure for the production of calcium carbonate and biomineralization ranging from 20 psi (first ¶ page 4); `9 psi (see last ¶ page 8); (i) 14.7 psi and (ii) <20 psi (Batch Reactor, ¶ 2.7.2, page 29; and entire document).
Regarding claims 8-9, Wilson et al., (US 10,125,303 B2) provide teaching suggestion and motivation regarding pumpable slurry compositions comprising: an aqueous carrier; an aggregate; urea; a calcium source; and a calcium carbonate producing agent comprising a microbe, an enzyme, or a combination comprising at least one of the foregoing; wherein the microbe comprises Sporosarcina pasteurii; Bacillus megaterium, Sporosarcina ureae; Pseudomonas aeruginosa; Proteus Vulgaris; Bacillus sphaericus; Myxococcus xanthus; Leuconostoc mesenteroides; Bacillus subtilis; Deleya halophila; Halomonas eurihalina, Proteus mirabilis; or Helicobacter pylori (see Abstract; Fig. 1-3; Col. 1, lines 25-55; claims; and entire document).
Regarding claim 10, Nemati et al., (Enz. Microbial Technol., 2003, Vol. 33: 635-642) provide teaching suggestion and motivation regarding optimization of enzyme concentration for calcium carbonate formation in Biomineralization (see Abstract; Fig. 1, page 637; Urease concentration ranging from 0.05-0.1 g/L, Results, ¶ 3.1, page 638; Fig. 3-4, page 639, enzyme concentrations in the range 0.01 g/L-0.1 g/L; Fig. 6, page 640; and entire document) and conclude increased calcium carbonated formation can be achieved via optimization of enzyme concentration: “The proportional increase of reactants and enzyme concentrations up to a certain level (urea, CaCl2·2H2O and urease: 36, 90 and 0.3 g l−1, respectively), as well as multiple injection of reaction medium had a marked effect on the extent of plugging, observed as a decrease in permeability of porous media” (Discussion, pages 641-642).
Therefore, it would have been obvious to a person of ordinary skill in the art to combine and modify the teachings of Dosier GK., by the methods of Kucharski et al., Paul VG., and Nemati et al., that suggest the advantages of optimization of pressure and enzyme concentration for calcium carbonate bonds are formed from biological activity of the urease-producing cells at a pressure that is greater than ambient pressure and utilize the pumping slurry as suggested by the teachings Wilson et al., in the claimed method for manufacturing a construction material of the instant invention and the cited combined references Dosier GK., Kucharski et al., Paul VG., Wilson et al., and Nemati et al., also provide the structural and functional elements of the instant invention (Teaching, Suggestion, Motivation and Expectation of Success).
Given this extensive teaching in prior art (Dosier GK., Kucharski et al., Paul VG., Wilson et al., and Nemati et al.,) i.e., “ a method for manufacturing a construction material, comprising: providing an aggregate mixture that includes a plurality of aggregate particles, urease-producing cells or cell spores thereof, a first composition comprising nutrients, and a second composition comprising a calcium source and a nitrogen source; and incubating the aggregate mixture for a period of time to form calcium carbonate bonds between at least a subset of the plurality of aggregate particles, the calcium carbonate bonds are formed from biological activity of the urease-producing cells at a pressure that is greater than ambient pressure…” and as claimed in claims 1-15 is not of innovation but of ordinary skill in the art and the expectation of success is extremely high i.e., “a person of ordinary skill has good reason to pursue the known options within his or her technical grasp. If this leads to the anticipated success, it is likely that product [was] not of innovation but of ordinary skill and common sense. In that instance the fact that a combination was obvious to try might show that it was obvious under § 103.”KSR, 550 U.S. at, 82 USPQ2d at 1397”.
Therefore, claims 1-15 are rejected under 35 U.S.C. 103(a) as being unpatentable over Dosier GK., (US 8,951,786 B1) and further in view of Kucharski et al., (US 8,182,604 B2), Paul VG., (PhD., Thesis., Missouri Univ. Sci. Technol., 2014, pages 1-257), Wilson et al., (US 10,125,303 B2) and Nemati et al., (Enz. Microbial Technol., 2003, Vol. 33: 635-642).
Allowable Subject Matter/Conclusion
None of the claims are allowable.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GANAPATHIRAMA RAGHU whose telephone number is (571)272-4533. The examiner can normally be reached on M-F 8:30am-5pm EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Mondesi can be reached on 408-918-7584. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/GANAPATHIRAMA RAGHU/ Primary Examiner, Art Unit 1652